CA2192602A1 - Induction de la differenciation cellulaire; apoptose et necrose de cellules malignes, comme dans la leucemie, a l'aide d'ozone et de synergies par des medicaments induisant la differenciation cellulaire - Google Patents

Induction de la differenciation cellulaire; apoptose et necrose de cellules malignes, comme dans la leucemie, a l'aide d'ozone et de synergies par des medicaments induisant la differenciation cellulaire

Info

Publication number
CA2192602A1
CA2192602A1 CA 2192602 CA2192602A CA2192602A1 CA 2192602 A1 CA2192602 A1 CA 2192602A1 CA 2192602 CA2192602 CA 2192602 CA 2192602 A CA2192602 A CA 2192602A CA 2192602 A1 CA2192602 A1 CA 2192602A1
Authority
CA
Canada
Prior art keywords
cell differentiation
synergies
apoptosis
necrosis
leukemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2192602
Other languages
English (en)
Other versions
CA2192602C (fr
Inventor
Thomas Ichim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2192602 priority Critical patent/CA2192602C/fr
Publication of CA2192602A1 publication Critical patent/CA2192602A1/fr
Application granted granted Critical
Publication of CA2192602C publication Critical patent/CA2192602C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 2192602 1996-12-11 1996-12-11 Induction de la differenciation cellulaire; apoptose et necrose de cellules malignes, comme dans la leucemie, a l'aide d'ozone et de synergies par des medicaments induisant la differenciation cellulaire Expired - Fee Related CA2192602C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2192602 CA2192602C (fr) 1996-12-11 1996-12-11 Induction de la differenciation cellulaire; apoptose et necrose de cellules malignes, comme dans la leucemie, a l'aide d'ozone et de synergies par des medicaments induisant la differenciation cellulaire

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2192602 CA2192602C (fr) 1996-12-11 1996-12-11 Induction de la differenciation cellulaire; apoptose et necrose de cellules malignes, comme dans la leucemie, a l'aide d'ozone et de synergies par des medicaments induisant la differenciation cellulaire

Publications (2)

Publication Number Publication Date
CA2192602A1 true CA2192602A1 (fr) 1998-04-10
CA2192602C CA2192602C (fr) 1999-04-20

Family

ID=4159426

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2192602 Expired - Fee Related CA2192602C (fr) 1996-12-11 1996-12-11 Induction de la differenciation cellulaire; apoptose et necrose de cellules malignes, comme dans la leucemie, a l'aide d'ozone et de synergies par des medicaments induisant la differenciation cellulaire

Country Status (1)

Country Link
CA (1) CA2192602C (fr)

Also Published As

Publication number Publication date
CA2192602C (fr) 1999-04-20

Similar Documents

Publication Publication Date Title
NZ334034A (en) Use of a melanoma differentiation associated gene (mda-7) for reversing a cancerous phenotype
AU2938595A (en) Mixing chamber arrangement
DE58906377D1 (en) Difluormethylverbindungen.
CA2276455A1 (fr) Phthalazinones
AU4019295A (en) Backpack or waistpack e.l. lighting arrangement
AU4778997A (en) Substituted 2,4-diamino-1,3,5-triazines as herbicides
IL138015A0 (en) Penetration-resistant ballistic article
AU4289697A (en) Tactical flashlight
AU5901994A (en) Tumor necrosis factor muteins
AU5021799A (en) Self-contained hyperbaric chamber
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
AU1874195A (en) Dual-view, immersible periscope
AU4557897A (en) Substituted 2-amino-4-alkylamino-1,3,5-triazines as herbicides
CY2483B1 (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation.
EP0628612A3 (fr) Compositions pigmentaires comportant des dispersants.
AU4779097A (en) Substituted 2-amino-4-alkylamino-1,3,5-triazines as herbicides
AU1044500A (en) Imidazonaphthyridines
AU1026999A (en) Substituted 2,4-diamino-1,3,5-triazines
AU4779197A (en) Substituted 2,4-diamino-1,3,5-triazines as herbicides
CY2538B1 (en) Tetrahydropyrido compounds
MXPA00001676A (es) Reconector tipo tel (circuito disyuntor montado en un poste)..
AU6500498A (en) Substituted 2,4-diamino-1,3,5-triazines as herbicides
CA2192602A1 (fr) Induction de la differenciation cellulaire; apoptose et necrose de cellules malignes, comme dans la leucemie, a l'aide d'ozone et de synergies par des medicaments induisant la differenciation cellulaire
ITTO920516A0 (it) Procedimento ed apparecchiatura per la rpoduzione, in particolare domestica, di bevande.
IL189502A0 (en) Methods and compositions for inhibiting neoplastic cell growth

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed